Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

NCT04137588 UNKNOWN

The purpose of this study is to explore the efficacy and safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Details

Lead sponsor	Peking University Cancer Hospital & Institute
Status	UNKNOWN
Enrolment	126
Start date	Wed Mar 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Advanced Non-squamous Non-small Cell Lung Cancer

Interventions

• Antiangiogenesis Agents
• Immune checkpoint inhibitor

Countries

China